Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 35.3% in 2022

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 181.3 million yuan in 2022, up 35.3% year-on-year.
Meanwhile, the company posted 1.6 billion yuan in revenue, up 3.8% year-on-year.
At the end of the reporting period, it had 5.2 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 49.6%.
This article was automatically produced by Caixin Automation on April 27, 2023.
Download our app to receive breaking news alerts and read the news on the go.
- PODCAST
- MOST POPULAR